Evogene
EVGN
18 hedge funds and large institutions have $33.6M invested in Evogene in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.
444% more capital invested
Capital invested by funds: $6.18M → $33.6M (+$27.5M)
2.78% more ownership
Funds ownership: 24.06% → 26.84% (+2.8%)
0% more funds holding
Funds holding: 18 → 18 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$7.54M |
| 2 |
SM
Senvest Management
New York
|
+$253K |
| 3 |
Jane Street
New York
|
+$144K |
| 4 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
+$62.5K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$50.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$767K |
| 2 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
-$591K |
| 3 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$380K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$333K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$323K |
EVGN Hedge Fund Activity: Q3 2020 in Review
18 of the 4,971 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q3 2020, worth a combined $33.6M — up 444% from $6.18M a quarter earlier.
Fund positioning in EVGN was balanced in Q3 2020: 7 funds opened new positions, 7 closed out, 5 added to existing stakes and 5 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $7.54M. The largest seller was Goldman Sachs, exiting entirely with an estimated $767K sold.
- 18 institutional investors held Evogene (EVGN) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $33.6M of Evogene stock for Q3 2020, up 444% quarter-over-quarter.
- 7 funds opened new Evogene positions in Q3 2020 and 7 closed out, a net change of 0 holders.
- The largest Evogene buyer in Q3 2020 was ARK Investment Management, an estimated $7.54M added.
- The largest Evogene seller in Q3 2020 was Goldman Sachs, an estimated $767K sold.
Based on aggregated 13F filings for Q3 2020.